We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+0.74%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$35.6B
AUM Growth
+$166M
Cap. Flow
+$350M
Cap. Flow %
0.98%
Top 10 Hldgs %
19.85%
Holding
1,363
New
118
Increased
473
Reduced
442
Closed
143

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$76.2M
2
SPGI icon
S&P Global
SPGI
+$73M
3
ADBE icon
Adobe
ADBE
+$62.1M
4
BMY icon
Bristol-Myers Squibb
BMY
+$56.5M
5
NVDA icon
NVIDIA
NVDA
+$52.5M

Top Sells

Rank Stock Value
1
BNY
Bank of New York Mellon
BNY
+$60.1M
2
CL icon
Colgate-Palmolive
CL
+$57.1M
3
CSCO icon
Cisco
CSCO
+$55.2M
4
GNRC icon
Generac Holdings
GNRC
+$44.8M
5
BABA icon
Alibaba
BABA
+$42.1M

Sector Composition

Rank Sector Weight
1 Technology 30.84%
2 Healthcare 17.62%
3 Consumer Discretionary 11.77%
4 Financials 10.38%
5 Industrials 7.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDXX icon
101
Idexx Laboratories
IDXX
$45.1B
$81.2M 0.23%
130,582
+70,619
+118% +$47.5M
LLY icon
102
Eli Lilly
LLY
$1.09T
$80.6M 0.23%
348,678
-10,658
-3% -$2.63M
CMCSA icon
103
Comcast
CMCSA
$87.7B
$80.2M 0.23%
1,434,562
-32,207
-2% -$1.88M
CGNX icon
104
Cognex
CGNX
$9.64B
$80.1M 0.22%
998,604
-42,243
-4% -$3.64M
SBUX icon
105
Starbucks
SBUX
$118B
$80.1M 0.22%
726,063
+29,323
+4% +$3.43M
ILMN icon
106
Illumina
ILMN
$29.3B
$79.6M 0.22%
201,802
-2,336
-1% -$1.07M
HDB icon
107
HDFC Bank
HDB
$123B
$78.9M 0.22%
2,158,140
+116,276
+6% +$4.31M
DIS icon
108
Walt Disney
DIS
$171B
$78.8M 0.22%
465,835
-695
-0.1% -$124K
FISV
109
Fiserv Inc
FISV
$29.7B
$78.7M 0.22%
725,548
+95,204
+15% +$10.6M
ZEN
110
DELISTED
ZENDESK INC
ZEN
$78.1M 0.22%
671,319
+100,944
+18% +$13M
AMAT icon
111
Applied Materials
AMAT
$357B
$78.1M 0.22%
606,841
-15,853
-3% -$2.15M
GM icon
112
General Motors
GM
$81.7B
$77.7M 0.22%
1,474,790
+97,130
+7% +$5.16M
BMY icon
113
Bristol-Myers Squibb
BMY
$130B
$76.7M 0.22%
1,295,663
+857,271
+196% +$56.5M
VRTX icon
114
Vertex Pharmaceuticals
VRTX
$124B
$76.5M 0.21%
421,889
+198,955
+89% +$38.8M
VEEV icon
115
Veeva Systems
VEEV
$33.7B
$76.4M 0.21%
264,996
+40,670
+18% +$12.9M
BSX icon
116
Boston Scientific
BSX
$69.2B
$76.3M 0.21%
1,757,866
+242,976
+16% +$10.7M
CMI icon
117
Cummins
CMI
$84.3B
$76M 0.21%
338,465
+161,610
+91% +$37.9M
AMBA icon
118
Ambarella
AMBA
$3.05B
$74.8M 0.21%
480,061
-21,462
-4% -$2.47M
ANSS
119
DELISTED
Ansys
ANSS
$73.7M 0.21%
216,465
-9,685
-4% -$3.5M
ABMD
120
DELISTED
Abiomed Inc
ABMD
$73.5M 0.21%
225,686
-10,538
-4% -$3.57M
SYK icon
121
Stryker
SYK
$135B
$73.4M 0.21%
278,259
+4,506
+2% +$1.2M
HPQ icon
122
HP
HPQ
$26.2B
$73.2M 0.21%
2,675,643
+563,098
+27% +$16.2M
IPGP icon
123
IPG Photonics
IPGP
$3.44B
$73M 0.2%
460,840
-19,671
-4% -$3.61M
BAC icon
124
Bank of America
BAC
$434B
$72.9M 0.2%
1,718,225
-142,312
-8% -$5.73M
EMR icon
125
Emerson Electric
EMR
$82.3B
$72.9M 0.2%
773,716
-260,040
-25% -$25.9M

Similar funds

Axa's Q3 2021 Portfolio in Review

As of Q3 2021, Axa held 1,363 positions worth $35.6B, up 0.47% from $35.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Axa's Q3 2021 filing shows 118 new, 473 increased, 442 reduced and 143 closed positions. Its largest new stake was GXO Logistics: 575,960 shares worth $45.2M. The largest sale was Bank of New York Mellon, an estimated $60.1M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q3 2021 buy was GXO Logistics: 575,960 shares worth $45.2M.
  • Axa added most to AT&T in Q3 2021, an estimated $76.2M increase.
  • Axa's biggest Q3 2021 reduction was Bank of New York Mellon, cutting an estimated $60.1M.
  • Axa fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $35.3M.
  • Axa's ten largest holdings make up 20% of its $35.6B portfolio in Q3 2021.
  • Axa opened 118 new positions and closed 143 in Q3 2021.
  • Axa's portfolio value rose 0.47% quarter-over-quarter to $35.6B.

Based on Axa's 13F filing for Q3 2021, filed 15 Nov 2021.